Skip to main content
logo
Remus Pharmaceuticals Limited (NSE:REMUS)
India flag India · Delayed Price · Currency is INR
616.40
+1.35 (0.22%)
Mar 6, 2026, 3:27 PM IST

Remus Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
7,17913,19210,163---
Market Cap Growth
-41.46%29.81%----
Enterprise Value
7,44013,16410,212---
Last Close Price
615.801118.05860.48---
PE Ratio
22.5045.3849.53---
PS Ratio
0.962.134.77---
PB Ratio
2.124.675.80---
P/TBV Ratio
2.415.346.83---
P/FCF Ratio
320.49439.73----
P/OCF Ratio
105.88189.00752.80---
EV/Sales Ratio
0.992.124.80---
EV/EBITDA Ratio
14.4729.2535.56---
EV/EBIT Ratio
15.1930.0436.68---
EV/FCF Ratio
332.12438.80----
Debt / Equity Ratio
0.050.080.080.420.030.09
Debt / EBITDA Ratio
0.310.500.490.710.040.21
Debt / FCF Ratio
7.157.66-3.080.040.10
Net Debt / Equity Ratio
-0.01-0.01-0.060.26-0.14-0.18
Net Debt / EBITDA Ratio
-0.10-0.09-0.370.44-0.22-0.41
Net Debt / FCF Ratio
-2.20-1.435.531.90-0.19-0.20
Asset Turnover
1.901.621.161.791.842.30
Inventory Turnover
9.0811.267.5322.888.9614.50
Quick Ratio
0.871.110.990.970.440.58
Current Ratio
1.611.821.511.390.840.98
Return on Equity (ROE)
18.30%16.79%24.98%66.14%71.37%40.49%
Return on Assets (ROA)
7.75%7.15%9.46%26.40%19.63%8.89%
Return on Invested Capital (ROIC)
11.64%16.06%23.77%53.60%77.53%47.79%
Return on Capital Employed (ROCE)
13.10%14.10%14.50%40.30%63.30%34.60%
Earnings Yield
4.67%2.20%2.02%---
FCF Yield
0.31%0.23%-0.19%---
Dividend Yield
0.16%0.07%0.09%---
Payout Ratio
1.76%4.06%2.88%---
Buyback Yield / Dilution
-3.88%-4.28%-38.35%-2.10%--
Total Shareholder Return
-3.72%-4.21%-38.27%-2.10%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.